Evidence map›Paper›PMID 26714121›Full record

ArticleTransplantation2016

iChoose Kidney: A Clinical Decision Aid for Kidney Transplantation Versus Dialysis Treatment.

Rachel E Patzer, Mohua Basu, Christian P Larsen, Stephen O Pastan, Sumit Mohan, Michael Patzer, Michael Konomos, William M McClellan, Janice Lea, David Howard and 2 more

Abstract readComparative StudyValidation Study
In one paragraph

Article in Transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Effect of the iChoose Kidney decision aid in improving knowledge about treatment options among transplant candidates: A randomized controlled trial.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2018
    Trial
  5. A Randomized Trial to Reduce Disparities in Referral for Transplant Evaluation.Journal of the American Society of Nephrology : JASN · 2017
    Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Assessing Deceased-Donor Kidneys Through Posttransplant Survival Prediction Algorithms.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  12. Review
  13. Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.Journal of the American Society of Nephrology : JASN · 2025
    Article
  14. Referral and Beyond: Restructuring the Kidney Transplant Process to Support Greater Access in the United States.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Rachel E Patzer1 Department of Surgery, Division of Transplantation, Emory University, Atlanta, GA. 2 Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA. 3 Emory University School of Medicine, Atlanta, GA. 4 Department of Medicine, Renal Division, Emory University School of Medicine, Atlanta, GA. 5 Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, NY. 6 Appex.io, Atlanta, GA. 7 Department of Health Policy and Management, Rollins School of Public Health, Atlanta, GA. 8 Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA.
Mohua Basu
Christian P Larsen
Stephen O Pastan
Sumit Mohan
Michael Patzer
Michael Konomos
William M McClellan
Janice Lea
David Howard
Jennifer Gander
Kimberly Jacob Arriola

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Minority Populations Prevention Researcher TrainingR25HD045810 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NEILANDS, TORSTEN BRIAN · 2003 to 2018
$4.3M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalKL2TR000455 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$2.9M
Atlanta Clinical and Translational Science Institute (KL2)KL2RR025009 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$2.9M
Atlanta Clinical and Translational Science Institute (TL1)TL1RR025010 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$1.1M
A regionally coordinated intervention to reduce racial disparities in access to kR24MD008077 · NIMHD · EMORY UNIVERSITY · PI PATZER, RACHEL E · 2013 to 2015
$916k
NCATS NIH HHS KL2 TR000455NCATS NIH HHS KL2TR000455NCATS NIH HHS UL1 TR000454NCATS NIH HHS ULL TR000454NCRR NIH HHS KL2 RR025009NCRR NIH HHS TL1 RR025010NCRR NIH HHS UL1 RR025008NICHD NIH HHS R25 HD045810NIMHD NIH HHS R24 MD008077NIMHD NIH HHS R24MD008077
6 · The paper itself

Abstract

backgroundDespite a significant survival advantage of kidney transplantation compared with dialysis, nearly one third of end-stage renal disease (ESRD) patients are not educated about kidney transplantation as a treatment option at the time of ESRD diagnosis. Access to individualized, evidence-based prognostic information is needed to facilitate and encourage shared decision making about the clinical implications of whether to pursue transplantation or long-term dialysis.

methodsWe used a national cohort of incident ESRD patients in the US Renal Data System surveillance registry from 2005 to 2011 to develop and validate prediction models for risk of 1- and 3-year mortality among dialysis versus kidney transplantation. Using these data, we developed a mobile clinical decision aid that provides estimates of risks of death and survival on dialysis compared with kidney transplantation patients.

resultsFactors included in the mortality risk prediction models for dialysis and transplantation included age, race/ethnicity, dialysis vintage, and comorbidities, including diabetes, hypertension, cardiovascular disease, and low albumin. Among the validation cohorts, the discriminatory ability of the model for 3-year mortality was moderate (c statistic, 0.7047; 95% confidence interval, 0.7029-0.7065 for dialysis and 0.7015; 95% confidence interval, 0.6875-0.7155 for transplant). We used these risk prediction models to develop an electronic, user-friendly, mobile (iPad, iPhone, and website) clinical decision aid called iChoose Kidney.

conclusionsThe use of a mobile clinical decision aid comparing individualized mortality risk estimates for dialysis versus transplantation could enhance communication between ESRD patients and their clinicians when making decisions about treatment options.

Indexed as

Choice BehaviorComputers, HandheldDecision Support TechniquesKidney TransplantationMobile ApplicationsPatient SelectionRenal DialysisAdultAgedAged, 80 and overCommunicationDecision Support Systems, ClinicalFemaleHealth Knowledge, Attitudes, PracticeHumansIncidence

Identifiers

PMID26714121
PMCPMC4658512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.